Organ Preservation Solution Market 2024 – Global Industry, Key Strategies, Analysis, Business Segmentation, Latest Technology And Outlook By 2033

The Organ Preservation Solution Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Organ Preservation Solution Market:
https://www.thebusinessresearchcompany.com/report/organ-preservation-solution-global-market-report

According to The Business Research Company’s Organ Preservation Solution Global Market Report 2024, The organ preservation solution market size has grown strongly in recent years. It will grow from $274.48 billion in 2023 to $295.92 billion in 2024 at a compound annual growth rate (CAGR) of 7.8%.  The  growth in the historic period can be attributed to rise in organ transplants, growing awareness of organ donation, expansion of healthcare infrastructure, increasing incidence of organ failure..

The organ preservation solution market size is expected to see strong growth in the next few years. It will grow to $406.07 billion in 2028 at a compound annual growth rate (CAGR) of 8.2%.  The growth in the forecast period can be attributed to rising demand for extended criteria organs, expansion of organ procurement programs, focus on organ quality and functionality, global initiatives to address organ shortage.. Major trends in the forecast period include application of preservation solutions in organ banking, market emphasis on extended preservation times, integration of additives for enhanced preservation, focus on portable and compact organ preservation devices, collaborations for research and innovation in organ preservation..

The rise in organ transplantation is expected to propel the growth of the organ preservation solution market going forward. Organ transplantation involves a surgical intervention where an organ or tissue is extracted from a donor and transferred to a recipient or relocated within the same individual. Organ preservation solutions had the ability to reduce organ damage during transportation and storage, enhancing the viability of the organ for successful transplantation. For instance, in January 2023, according to the Organ Procurement and Transplantation Network (OPTN), a US-based public-private partnership that links all professionals involved in the U.S. donation and transplantation system, a total of 42,887 organ transplants were performed in 2022, representing a 3.7 percent increase compared to the 41,354 transplants conducted in 2021. Notably, kidney transplants accounted for a significant portion, with 25,000 procedures performed, demonstrating a 3.4 percent growth in the United States. Therefore, the rise in organ transplantation drives the organ preservation solution market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=11903&type=smp

The organ preservation solution market covered in this report is segmented –

1) By Solution Type: Viaspan, Custodiol-HTK (Histidine-Tryptophan-Ketoglutarate), Renograf, Hypothermosol, Perfadex, Lifor, HBS (Hyperosmotic Blood Substitute) Solution, siRNA (Small Interfering RNA) Transplant Solutions, Other Solution Types

2) By Organ Type: Kidneys, Liver, Lung, Heart, Other Organ Types

3) By Technique: Static Cold Storage (SCS) Technique, Hypothermic Machine Perfusion, Other Techniques

Top Major Players
Bristol-Myers Squibb Company
Baxter International Inc
Teva Pharmaceutical Industries Ltd.
Accord Healthcare
BioLife Solutions Inc.

Product innovation is a key trend gaining popularity in the organ preservation solution market. Major companies operating in the organ preservation solution market are focused on developing innovative products to strengthen their position and gain a competitive advantage. For instance, in October 2021, Paragonix Technologies Inc., a US-based provider of donor organ preservation and transport systems, launched the LIVERguard Donor Liver Preservation System, a new preservation and transport system for clinical and commercial use in the US and Europe. This system offers a meticulously regulated and advanced setting for hypothermic liver preservation, accompanied by real-time digital monitoring to ensure the protection of a donor’s liver throughout the entire transplant process, from donation to transplantation.

The organ preservation solution market report table of contents includes:
1. Executive Summary
2. Organ Preservation Solution Market Characteristics
3. Organ Preservation Solution Market Trends And Strategies
4. Organ Preservation Solution Market – Macro Economic Scenario
5. Global Organ Preservation Solution Market Size and Growth
…………………………….
32. Global Organ Preservation Solution Market Competitive Benchmarking
33. Global Organ Preservation Solution Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Organ Preservation Solution Market
35. Organ Preservation Solution Market Future Outlook and Potential Analysis
36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model